-
-
-
-
-
-
-
Mizuho stays Outperform rated on Eikon Therapeutics Inc. (EIKN) following FY25 earnings and pipeline update
-
-
-
-
-
-
-
Eikon Therapeutics Opens At $17.05, IPO Priced At $18
-
-
-
479,069 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


